New York PMP/I-STOP for PMHNPs and Psychiatrists: When to Check It and How to Document It
For New York psychiatrists and PMHNPs, checking the Prescription Monitoring Program Registry is a recurring part of the controlled substance prescribing workflow, required at the time of each qualifying prescription or dispensing event, not only during intake.
Before prescribing or dispensing a Schedule II, III, or IV controlled substance, most practitioners are required to consult the PMP Registry and document either that consultation or the applicable exception in the patient medical chart. The controlled substance history pulled from the registry needs to be current within 24 hours of that prescribing or dispensing event, unless a defined exception applies.
These requirements are set out in 10 NYCRR §80.63.
This guide focuses on that PMP step: when consultation is required, what the report provides, how practitioners access it, when a designee may retrieve information, which exceptions matter, and what needs to be documented.
What are I-STOP and the New York PMP Registry?
I-STOP refers to New York's Internet System for Tracking Over-Prescribing reforms, and the PMP Registry is the secure system practitioners use to review reported controlled-substance dispensing histories.
The New York State Department of Health PMP/I-STOP program provides PMP access through the Health Commerce System, or HCS. The registry is available 24 hours a day, seven days a week. Current patient reports include controlled substances dispensed in New York State and reported by pharmacies or other dispensers for the preceding year.
In practice, clinicians often use "I-STOP" and "PMP" interchangeably.
Who has to check the PMP in New York?
Most New York practitioners must consult the PMP before prescribing or dispensing a controlled substance in Schedule II, III, or IV, subject to the exceptions listed in10 NYCRR §80.63.
The general mandatory consultation rule in §80.63(c) does not include Schedule V. Practitioners should verify a medication's current controlled-substance schedule rather than relying on memory or a general medication category.
When does the PMP check have to happen?
The patient's controlled-substance history must be obtained from the PMP no more than 24 hours before the practitioner prescribes or dispenses the qualifying controlled substance.
A PMP search completed weeks earlier at intake does not satisfy a later prescribing event. For a later Schedule II, III, or IV prescription, apply the consultation rule again unless a defined exception applies.
For many outpatient psychiatric practices, placing the PMP review close to the prescribing event reduces the risk of relying on an older report.
What information does the New York PMP show?
The PMP gives practitioners access to reported controlled-substance dispensing history for use in prescribing decisions.
New York's current PMP materials state that reports include controlled substances dispensed in the state and reported by pharmacies or dispensers during the preceding year. The history can include prescription and dispensing information relevant to the patient's controlled-substance treatment.
An unexpected entry may call for clarification. A prescription from another practitioner, a recent fill, or overlapping medication can have several possible explanations. The PMP provides another source of information to consider with the patient's history and current clinical assessment.
For deeper practice rules about how controlled-substance findings affect prescribing decisions, see CHW's guide to Controlled-Substance Prescribing Policies for a Telepsychiatry Practice.
What is the basic PMP workflow before prescribing?
A dependable PMP process ties the registry check to the prescription rather than treating it as a separate administrative task.
A practical sequence is:
Confirm whether the prescription involves a Schedule II, III, or IV controlled substance and whether a recognized exception applies.
Retrieve the correct patient's PMP history within the required period.
Review the reported controlled-substance history for information relevant to the prescribing decision.
Clarify material discrepancies when clinically appropriate.
Make the prescribing decision based on the full clinical picture, informed by the PMP information.
Document the PMP consultation in the patient's chart.
This same trigger should be considered when controlled-substance refill requests arrive between appointments. A refill queue, EHR task, or staff workflow can help prevent a prescription from moving forward without the required review.
PMP review is separate from electronic prescription transmission. CHW's guide to EPCS for PMHNPs and Psychiatrists in New York covers electronic-prescribing and credential requirements.
How do prescribers access the New York PMP Registry?
New York licensed prescribers access the PMP Registry through the Health Commerce System, and each prescriber or authorized designee needs an individual HCS account.
The current NYSDOH PMP FAQ states that there is no separate PMP registration once the HCS account has been established. Users access the PMP application through HCS, and multi-factor authentication must currently be configured before PMP application access.
HCS credentials are individual. New York's HCS guidance prohibits sharing user IDs and passwords.
For clinicians setting up these systems as part of a new practice, CHW's How to Start a Telepsychiatry Private Practice in New York guide covers the broader launch sequence.
Can a staff member or designee check the PMP for you?
Yes. New York permits a practitioner to authorize a designee to consult the PMP Registry on the practitioner's behalf, subject to defined conditions. The practitioner still makes the prescribing or dispensing decision.
Under the current rule, the designee must:
be located in New York State when accessing the PMP;
be employed by the same professional practice or under contract with that practice;
have an individual HCS account; and
use registry information only for authorized purposes.
The practitioner must take reasonable steps to confirm that the designee can use the registry appropriately and understands applicable privacy obligations.
The practitioner must keep designee authorizations current. When a designee's employment, contract, or authorization ends, §80.63 requires notification of the revocation.
For distributed practices, the physical-location rule deserves attention. A designee accessing the New York PMP under this provision must be in New York at the time of access.
What exceptions can allow prescribing without a PMP consultation?
New York recognizes defined exceptions to the PMP consultation duty. When an exception is used, the applicable basis must be documented in the patient's chart.
Care-setting exceptions
The regulation includes exceptions for circumstances such as administration of a controlled substance, certain institutional settings, qualifying emergency-department prescribing, hospice care, and other situations listed in §80.63( c)(2).
Some of these exceptions have limits. For example, the emergency-department exception is tied to a prescription that does not exceed a five-day supply.
Access, delay, and system exceptions
An exception may apply when timely registry access is not reasonably possible, no other practitioner or authorized designee is reasonably available, and the prescription does not exceed a five-day supply.
A separate exception can apply when consultation would delay the prescription enough to adversely affect the patient's medical condition. That exception is subject to a five-day-supply limit and added chart-documentation requirements.
The regulation covers situations where the registry is officially unavailable or cannot be accessed through a qualifying temporary technological or electrical failure.
Commissioner waivers
The regulation permits time-limited waivers in defined circumstances involving technological limitations or another qualifying exceptional circumstance. A waiver requires an application.
Ordinary scheduling pressure, a forgotten login, or an inconvenient refill request does not appear among the listed exceptions.
How should PMP consultation be documented?
New York requires the practitioner to document the PMP consultation in the patient's medical chart. When the PMP is not consulted, the chart must state the reason and identify the specific exception relied upon.
For a routine consultation, a concise entry may state:
NYS PMP Registry reviewed within 24 hours before controlled-substance prescribing; relevant history considered in the prescribing decision.
If an exception applies, the record should identify it and include any extra information required for that category. The limited-access exception requires documentation of the barriers to registry access and efforts to contact available designees. The adverse-delay exception requires documentation explaining the circumstances, expected delay, and relationship to the patient's medical condition.
Avoid vague chart language such as "I-STOP compliant." It does not document the action taken.
To learn more about controlled-substance record categories, storage, and retention, see CHW's DEA Recordkeeping for Telehealth Psychiatrists and PMHNPs guide.
Does telehealth change the PMP requirement?
Telehealth does not create a blanket exemption from New York's PMP consultation rule.
The New York State Bureau of Narcotic Enforcement states in guidance updated July 2026 that controlled substances may be prescribed through telemedicine or telehealth in circumstances permitted by state law and applicable DEA rules. The same guidance states that practitioners must still comply with New York PMP consultation requirements for Schedule II, III, and IV prescriptions.
A telehealth prescriber may need to answer two separate questions: whether the prescription is permitted through telehealth and whether PMP consultation is required. This article addresses the PMP question. Broader telehealth prescribing rules belong in CHW's telepsychiatry and controlled-substance prescribing guides.
What PMP mistakes create avoidable workflow problems?
Most preventable PMP problems come from failing to connect the registry review to the qualifying prescribing event.
Common examples include:
relying on an intake PMP review for later prescriptions;
using a report obtained outside the permitted 24-hour period;
completing the consultation without documenting it;
sharing HCS credentials;
using a designee who does not meet current authorization requirements; and
treating telehealth status or ordinary inconvenience as an exception.
A short, repeatable workflow can make these errors easier to catch before a prescription is issued.
Where does Clarity Health + Wellness fit into a New York psychiatric practice?
Clarity Health + Wellness provides professional practice infrastructure for qualified independent practitioners. PMP access and controlled-substance prescribing remain within the clinician's own practice operations.
CHW does not perform a member's PMP review through membership, make prescribing decisions for members, or require access to a clinician's HCS or EPCS credentials. The practitioner remains responsible for clinical records, PMP workflows, prescribing systems, and controlled-substance documentation.
For psychiatrists and PMHNPs who need a professional Manhattan setting for a hybrid or independent practice, CHW can provide professional practice infrastructure and reservable clinical rooms under its current membership model. That setting does not replace the clinician's prescribing responsibilities.
Make the PMP check part of the prescription workflow
For New York psychiatrists and PMHNPs, the core process is manageable: determine when PMP consultation applies, retrieve the history within the permitted period, review relevant information, document the consultation, and know when a defined exception changes that sequence.
Tying the PMP check to controlled-substance prescribing and refill workflows makes it easier to apply the rule consistently. Access permissions, designee rules, and exception documentation can then sit within the same process.
If you are building that practice in New York and need a professional address, reservable clinical rooms, and mail handling to support it, explore Clarity Health + Wellness Virtual Membership to see how it fits alongside the clinical and administrative systems you manage yourself.
Frequently Asked Questions About New York PMP/I-STOP for PMHNPs and Psychiatrists
-
Most New York PMHNPs must consult the PMP Registry before prescribing or dispensing Schedule II, III, or IV controlled substances unless a defined exception applies.
-
The consultation rule applies before qualifying Schedule II, III, or IV prescribing or dispensing unless an exception applies. A prior search does not satisfy a later prescription when the history falls outside the permitted 24-hour period.
-
The patient's controlled-substance history must be obtained from the registry no more than 24 hours before the qualifying prescribing or dispensing event.
-
The general mandatory consultation provision in 10 NYCRR §80.63(c) names Schedule II, III, and IV controlled substances. Schedule V is not included in that general rule.
-
A properly authorized designee can retrieve PMP information for the practitioner when New York's designee requirements are met. The practitioner remains responsible for the prescribing decision.
-
No. Prescribers and authorized designees need individual HCS accounts, and HCS security rules prohibit credential sharing.
-
A qualifying registry outage or temporary technological or electrical failure can fall within a recognized exception. The practitioner must document the reason consultation did not occur and comply with the requirements attached to that exception.
-
No. Current New York guidance states that applicable PMP consultation requirements continue to apply to Schedule II, III, and IV prescribing through telehealth.
Educational Disclaimer
This article provides general educational information and is not legal advice, regulatory advice, or individualized professional guidance. Requirements can vary based on profession, prescribing authority, controlled-substance activities, patient locations, state authorization, practice structure, and individual circumstances. Clinicians should verify current requirements directly with applicable federal and New York authorities and qualified legal or regulatory counsel when appropriate.
About Clarity Health + Wellness
Clarity Health + Wellness is a therapist-led office and membership space in Midtown Manhattan founded by Dr. Logan Jones. Located on Fifth Avenue, CHW offers flexible therapy room rentals, professional memberships, and a more connected private-practice experience for mental health clinicians and aligned wellness professionals who want a space that feels polished, calm, and clinically appropriate without taking on the burden of a traditional lease.
Members can choose from On-Demand, Virtual, and Club options depending on how they practice. Offerings include furnished therapy suites, flexible room booking through Skedda, a compliant NYC business address for eligible professional use, and access to community features such as events, networking, and Clarity Chats through Club Membership.
Clarity Health + Wellness is especially known for combining sophisticated design, flexibility, and therapist-centered community in a way that supports both client experience and long-term practice growth.
Last reviewed: September 2026